Shira Zelber-Sagi is an expert in Hepatology at Tel Aviv Sourasky Medical Center (Israel). As of October 2026, ScienceLeadR ranks Shira Zelber-Sagi in the top 1% of experts worldwide for MASH and Body Weight. Shira Zelber-Sagi has authored 283 publications, the most recent in 2026, and is an investigator in 8 clinical trials. SLR score: 1,200 (community average: 125). How the SLR is computed.

LeadR Profile

Shira Zelber-Sagi Tel Aviv Sourasky Medical Center Israel
1 200 ScienceLeadR Reputation 1200
Network Map

Hepatology

Subspecialties: Gastroenterology - Nutrition - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2006 - 2026

Source: PubMed

University of Haifa

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
The dynamic spectrum of steatotic liver disease: the global perspective.
PMID 42567912 — liver diseases, fibrosis, liver, therapeutics, alcohol drinking
Nat Rev Gastroenterol Hepatol Top journal20260
Sleep and Sedentary Behavior Predict Severity in MASLD but Not MetALD/ALD: A Compositional Analysis.
PMID 42933688 — exercise, sleep, liver, sedentary behavior, movement, liver stiffness
JHEP Rep20260
Changing epidemiology and etiology of hepatocellular carcinoma in Europe: implications for clinical practice and health policy.
PMID 42820245 — liver diseases, epidemiology, carcinoma, hepatocellular, neoplasms, liver, liver neoplasms
Lancet Reg Health Eur20261
Gender differences in stigma and care avoidance among people living with MASLD: an international survey.
PMID 42686023 — liver diseases, non-alcoholic fatty liver disease, liver, retention in care, sex characteristics, sex differences
JHEP Rep20260
Steatotic liver disease trajectory: A holistic EASL guidance on the multidisciplinary approach to screening and patient management.
PMID 42617506 — liver diseases, multiple chronic conditions, liver
JHEP Rep20264

Clinical Studies 8

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 6
Phase 2 1
Phase 3 1

By status:

Completed 4
Unknown 3
Recruiting 1

By type:

Interventional 6
Observational 2

By Monocentric/Multicentric:

monocentric 7
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

LeadR Networks

Main global connection map